Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-22 Sale | 2026-06-24 4:04 pm | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 2,500 | $35 | $87,500 | 10,125 (Direct) | View |
| 2026-05-26 Sale | 2026-05-28 4:19 pm | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 2,500 | $29.17 | $72,925 | 12,625 (Direct) | View |
| 2026-02-20 Sale | 2026-02-24 4:58 pm | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 4,000 | $36.36 | $145,440 | 12,722 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-02 Exercise | 2026-09-03 7:02 pm | N/A 2034-01-23 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 4,600 | $0 | 128,664 (Direct) | View |
| 2026-09-02 Exercise | 2026-09-03 7:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 3,286 | $24.2 | 128,664 (Direct) | View |
| 2026-09-02 Exercise | 2026-09-03 7:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 694 | $12.7 | 128,664 (Direct) | View |
| 2026-09-01 Tax Withholding | 2026-09-03 7:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 928 | $47.5 | 128,664 (Direct) | View |
| 2026-09-02 Exercise | 2026-09-03 7:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 620 | $18.7 | 128,664 (Direct) | View |
| 2026-09-01 Tax Withholding | 2026-09-03 7:01 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 874 | $47.5 | 61,622 (Direct) | View |
| 2026-09-01 Tax Withholding | 2026-09-03 6:59 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 2,424 | $47.5 | 273,362 (Direct) | View |
| 2026-09-01 Tax Withholding | 2026-09-03 6:59 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 877 | $47.5 | 50,559 (Direct) | View |
| 2026-07-08 Option Award | 2026-07-10 9:53 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. EVP, Chief Medical Officer | 24,400 | $0 | 35,025 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:12 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 7,394 | $0 | 7,394 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2034-03-27 | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 16,769 | $0 | 16,769 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 31,700 | $0 | 31,700 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 7,394 | $0 | 7,394 (Direct) | View |
| 2026-06-17 Option Award | 2026-06-22 4:11 pm | N/A 2035-01-29 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 7,394 | $0 | 7,394 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 6:03 pm | N/A 2033-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 3,381 | $0 | 101,940 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 6:03 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 928 | $29.86 | 101,940 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 6:03 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 2,181 | $12.7 | 101,940 (Direct) | View |
| 2026-06-01 Exercise | 2026-06-03 6:03 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 1,200 | $18.7 | 101,940 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 6:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 874 | $29.86 | 61,996 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 6:02 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 850 | $29.86 | 34,003 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 6:01 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 2,424 | $29.86 | 279,593 (Direct) | View |
| 2026-06-01 Tax Withholding | 2026-06-03 6:01 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 877 | $29.86 | 50,936 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director | 5,750 | $0 | 18,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 5,750 | $0 | 18,472 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:49 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | MILLER MICHAEL PATRICK Director | 5,750 | $0 | 5,937 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:49 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director | 5,750 | $0 | 18,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:49 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director | 5,750 | $0 | 16,375 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:48 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Frohlich Mark W Director | 5,750 | $0 | 7,000 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 8:48 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director | 5,750 | $0 | 15,125 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-24 4:58 pm | N/A 2026-05-11 | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 4,000 | $0 | 12,722 (Direct) | View |
| 2026-02-20 Exercise | 2026-02-24 4:58 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director | 4,000 | $24 | 12,722 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 5:06 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 19,497 | $0 | 51,813 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 5:06 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 53,915 | $0 | 282,017 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 5:06 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 18,894 | $0 | 34,853 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 5:06 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 19,430 | $0 | 62,870 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 5:06 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 20,636 | $0 | 76,337 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 3,546 | $34.62 | 55,701 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 3,546 | $34.62 | 32,316 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 3,546 | $34.62 | 43,440 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 7,607 | $34.62 | 228,102 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:50 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer | 3,758 | $34.62 | 15,959 (Direct) | View |
| 2026-02-02 Tax Withholding | 2026-02-04 4:21 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer | 5,718 | $36.01 | 46,986 (Direct) | View |
| 2026-02-02 Tax Withholding | 2026-02-04 4:21 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer | 5,488 | $36.01 | 59,247 (Direct) | View |
| 2026-02-02 Tax Withholding | 2026-02-04 4:20 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec | 3,968 | $36.01 | 35,862 (Direct) | View |
| 2026-01-26 Exercise | 2026-02-04 4:20 pm | N/A 2026-01-26 | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 80,000 | $0 | 235,709 (Direct) | View |
| 2026-01-26 Exercise | 2026-02-04 4:20 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 40,000 | $27.4 | 235,709 (Direct) | View |
| 2026-01-26 Tax Withholding | 2026-02-04 4:20 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 70,635 | $37 | 235,709 (Direct) | View |
| 2026-02-02 Tax Withholding | 2026-02-04 4:20 pm | N/A N/A | RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President | 14,110 | $36.01 | 235,709 (Direct) | View |
| 2026-02-01 Option Award | 2026-02-03 4:09 pm | N/A 2036-02-01 | RIGEL PHARMACEUTICALS INC | RIGL | MILLER MICHAEL PATRICK Director | 12,000 | $0 | 12,000 (Direct) | View |